Neuronetics, Inc. STIM recently announced the FDA 510(k) clearance of NeuroStar Advanced Therapy for usage as a supplement to treat major depressive disorder (MDD) in adolescents aged between 15 and ...
MALVERN, Pa., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for ...
NeuroStar Advanced Therapy for Mental Health is a transcranial magnetic stimulation system that uses magnetic fields to reignite dormant synapses in the brain. The Food and Drug Administration (FDA) ...
NeuroStar Advanced Therapy is a transcranial magnetic stimulation system that uses magnetic fields to induce neural activity in the cerebral cortex. The Food and Drug Administration (FDA) has cleared ...
MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for ...
Neuronetics, Inc. STIM recently announced that it has agreed to acquire all outstanding shares of Greenbrook TMS Inc., a magnetic neurostim company, in an all-stock transaction. The acquisition is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results